601 264 6000


In the Media: Rambod Rouhbakhsh, MD

Covid-19 Vaccine: EUA vs. FDA Approval Process

Earlier this month, Moderna became the second company to apply for full U.S. Food and Drug Administration (FDA) approval of its Covid-19 vaccine. Currently, both Pfizer and Moderna mRNA vaccines are on the US market under an emergency use authorization (EUA), which was granted by the FDA in December.

Rambod Rouhbakhsh, MD, who led Hattiesburg Clinic’s Moderna Covid-19 vaccine clinical trial, spoke to Mississippi Public Broadcasting and WJTV about the approval process and what full FDA approval would likely mean for the future of the Covid-19 vaccines.

“It may incidentally raise public confidence in the vaccines. The companies can also market directly to consumers at that point, which they’ve been unable to do up until now,” Dr. Rouhbakhsh said. “And then from a legal standpoint, businesses including the U.S. military will be able to require employees to be vaccinated before being able to work.”

To learn more, follow the links to see the full interview: WJTVMississippi Public Broadcasting

Tate Rutland


view all posts